About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Xrcc6tm1Fwa
targeted mutation 1, Frederick W Alt
MGI:2179954
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Xrcc6tm1Fwa/Xrcc6tm1Fwa involves: 129S6/SvEvTac MGI:5013918
hm2
Xrcc6tm1Fwa/Xrcc6tm1Fwa involves: 129S6/SvEvTac * C57BL/6J MGI:3641421
cx3
Ightm2Cgn/Igh+
Xrcc6tm1Fwa/Xrcc6tm1Fwa
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 MGI:3769719


Genotype
MGI:5013918
hm1
Allelic
Composition
Xrcc6tm1Fwa/Xrcc6tm1Fwa
Genetic
Background
involves: 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Xrcc6tm1Fwa mutation (2 available); any Xrcc6 mutation (61 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• adult mice exhibit normal nervous system function
• cerebellar development is normal
• at E12.5, mice exhibit increased apoptotic cells in the developing spinal cord, cerebral cortex, diencephalon, midbrain, and hindbrain compared to in wild-type mice
• apoptosis in the cerebral cortex is less severe than in Lig4tm1Fwa
• apoptotic cells are localized within or superficial to the ventricular zone
• neuron apoptosis coincides with embryonic neurogenesis
• cavities at variable frequency and less severe than in Lig4tm1Fwa
• cavities at variable frequency and less severe than in Lig4tm1Fwa
• cavities at variable frequency and less severe than in Lig4tm1Fwa

cellular
• mouse embryonic fibroblasts exhibit leakiness of residual end joining in a transient V(D)J recombination end joining assay compared with wild-type cells
• at E12.5, mice exhibit increased apoptotic cells in the developing spinal cord, cerebral cortex, diencephalon, midbrain, and hindbrain compared to in wild-type mice
• apoptosis in the cerebral cortex is less severe than in Lig4tm1Fwa
• apoptotic cells are localized within or superficial to the ventricular zone
• neuron apoptosis coincides with embryonic neurogenesis




Genotype
MGI:3641421
hm2
Allelic
Composition
Xrcc6tm1Fwa/Xrcc6tm1Fwa
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Xrcc6tm1Fwa mutation (2 available); any Xrcc6 mutation (61 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• animals are significantly smaller than controls, but they are viable and fertile
• organ weights are proportional to body weight
• mice weigh 50-60% that of controls at all ages tested

cellular
• in Rag1 and Rag2 transfected mutant MEFs, recovery of plasmids harboring recombination signal sequence (RS) joins is reduced by 10 to 20-fold, while that of plasmids harboring coding joins is reduced by 200-fold
• in MEF populations sychronized by serum starvation, gamma-irradiation at G1 and G2/M resulted in permanant arrest of cells whereas control cells recovered by resuming the cell cycle
• in asynchronus populations, gamma- irradiated mutant MEFs arrest at G2/M
• homozygous mutant ES cells accumulate at G2/M after exposure to gamma-irradiation prior to apoptosis
• 40% fewer mutant MEFs are in S phase in asynchronous cell populations compared to controls
• in cells synchronized by serum starvation, both control and mutant cells reentered S phase by 10 hours, but fewer mutant cells are in S phase between 10 and 24 hours; in addition, at 48 hours fewer mutant cells had replicated and many of these were still in G0/G1
• the growth rate of mutant MEFs is lower than controls, especially at later passages
• mutant MEFs stop growing earlier than control MEFs

immune system
• both D-J and V-DJ rearrangements are detectable in mutant bone marrow DNA but are greatly reduced (more than 100-fold) in level compared to controls, so functional Ig rearrangements can be generated at low frequency
• no B220+CD43-IgM+ cells are detectable in mutant bone marrow
• at the pro-B cell stage in mutant mice
• in spleens of mutant mice aged 3-18 weeks, no mature B220+IgM+ B lineage cells are detected
• no B lineage cells are detected in the peritoneal cavity of mutant mice
• no B220+CD43-IgM- cells are detectable in mutant bone marrow
• very few viable thymocytes
• T cell differentiation is impaired
• the level of recombination signal sequence (RS) joins in mutant thymocyte DNA is substantially reduced compared to controls and the recovered joins are imprecise
• both Tcrbeta D-J and V-DJ rearrangements are detectable in thymic DNA but are variably reduced in level compared to controls
• the thymus from mutant mice usually contain more than 50% double positive lineage cells
• CD4+ and CD8+ cells are both detectable but at about 100-fold lower levels than controls
• no detectable serum IgM

neoplasm
• 6 of 40 mice (aged 2-7 months) developed thymic tumors; two of these tumors were characterized as CD4+ CD8+ TCRbeta-

behavior/neurological
• females are unable to nurse their newborns and pups require a foster mother for survival

hematopoietic system
• both D-J and V-DJ rearrangements are detectable in mutant bone marrow DNA but are greatly reduced (more than 100-fold) in level compared to controls, so functional Ig rearrangements can be generated at low frequency
• no B220+CD43-IgM+ cells are detectable in mutant bone marrow
• at the pro-B cell stage in mutant mice
• in spleens of mutant mice aged 3-18 weeks, no mature B220+IgM+ B lineage cells are detected
• no B lineage cells are detected in the peritoneal cavity of mutant mice
• no B220+CD43-IgM- cells are detectable in mutant bone marrow
• very few viable thymocytes
• T cell differentiation is impaired
• the level of recombination signal sequence (RS) joins in mutant thymocyte DNA is substantially reduced compared to controls and the recovered joins are imprecise
• both Tcrbeta D-J and V-DJ rearrangements are detectable in thymic DNA but are variably reduced in level compared to controls
• the thymus from mutant mice usually contain more than 50% double positive lineage cells
• CD4+ and CD8+ cells are both detectable but at about 100-fold lower levels than controls
• no detectable serum IgM

endocrine/exocrine glands
• very few viable thymocytes
• 6 of 40 mice (aged 2-7 months) developed thymic tumors; two of these tumors were characterized as CD4+ CD8+ TCRbeta-




Genotype
MGI:3769719
cx3
Allelic
Composition
Ightm2Cgn/Igh+
Xrcc6tm1Fwa/Xrcc6tm1Fwa
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ightm2Cgn mutation (1 available); any Igh mutation (43 available)
Xrcc6tm1Fwa mutation (2 available); any Xrcc6 mutation (61 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mice carrying a rearranged IgH (heavy chain) variable region from a B1-8 clone and homozygous for Xrcc6tm1Fwa exhibit small but detectable populations of peripheral kappa-light chain expressing IgM+ B cells with functional light chain rearrangements; this indicates that some light chain rearrangment can occur in Xrcc6-deficient mice and the defect in B cell differentiation is "leaky"

hematopoietic system
• mice carrying a rearranged IgH (heavy chain) variable region from a B1-8 clone and homozygous for Xrcc6tm1Fwa exhibit small but detectable populations of peripheral kappa-light chain expressing IgM+ B cells with functional light chain rearrangements; this indicates that some light chain rearrangment can occur in Xrcc6-deficient mice and the defect in B cell differentiation is "leaky"





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory